Erector Spinae Plane Block for Postoperative Pain Management

Not Applicable

Completed

• Conditions: Post Operative Pain; Pain
• Interventions: Procedure: Control; Procedure: Erector spinae plane block

• Registration Number: NCT05697315
• Lead Sponsor: Kahramanmaras Sutcu Imam University

Brief Summary

Erector spinae plane (ESP) block is an interfacial plane block with visceral and somatic analgesic activity at paraspinal muscles. This study aims to examine the postoperative analgesic efficacy of ESP block after cesarean section (CS) with Pfannenstiel incision under spinal anesthesia.

Detailed Description

The study included 54 patients with mild systemic disease (ASA II patients) who would undergo elective CS under spinal anesthesia. They were randomly divided into an ESP block group (Group E) and a control group (Group C). After the surgery, Group E patients underwent ultrasound-guided bilateral ESP block with 20 ml of 0.25% bupivacaine at the lateral decubitus position, while Group C received no intervention. Patients in both groups received parenteral patient-controlled analgesia. The patients' post-operative 24-hour opioid consumption, regular Visual Analogue Scale (VAS) measurements, and need for rescue analgesics were evaluated. Statistical analysis was performed using SPSS 21 program. Demographic and other data were assessed using independent samples t-test, Mann-Whitney U test, and Chi-square analysis.

Study Timeline

• Study Start: 2021-12-01
• Primary Completion: 2022-04-01
• Study Completion: 2022-04-01
• Status Verified: 2023-01
• Study First Submitted: 2023-01-04
• Study First Submitted QC: 2023-01-16
• Last Update Submitted: 2023-01-16
• Study First Posted: 2023-01-25
• Last Update Posted: 2023-01-25

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 56

Inclusion Criteria

• ASA II patients
• 18-45 years who underwent CS with Pfannenstiel incision under spinal anesthesia
• agreed to participate in the study

Exclusion Criteria

• Patients with infection at the injection site
• Coagulopathy Allergy to amide-type local anesthetics
• History of peripheral neuropathy
• Hepatic and/or renal failure
• Refusing the procedure
• patients with heart disease

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Arm && Interventions

Group	Intervention	Description
Control group	Control	No block was performed, tramadol was administered with patient-controlled analgesia (PCA) and all patients were followed in the ward.
Erector spinae plane block	Erector spinae plane block	Erector spinae plane block was performed, tramadol was administered with patient-controlled analgesia (PCA) and all patients were followed in the ward.

Primary Outcome Measures

Name	Time	Method
24-hour opioid consumption	up to 24 hour	The amount of tramadol consumed in milligrams in the first 24 hours was determined with a patient-controlled analgesia pump.

Secondary Outcome Measures

Name	Time	Method
Visual Analog Scale (Vas)	0, 30 minutes, 1 hour, 2 hours, 6 hours, 12 hours, 24 hours	pain scores,graded from 0 to 10, 0 no pain, 10 highest pain experienced

Trial Locations

Locations (1)

Kahramanmaras Sutcu Imam University; 🇹🇷 Kahramanmaraş, Turkey